Jason D. Hanson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
enGene Therapeutics Inc. (ENGN)
SEC 8-K
Current2023-10-31–present
-
Start not stated–2024-07-21
-
Start not stated–2024-07-21
-
Start not stated–2024-02-14
-
Start not stated–2024-02-14
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | enGene Therapeutics Inc. (ENGN) | Former Chief Executive Officer | $427,283 | $999,299 |
| 2023 | enGene Therapeutics Inc. (ENGN) | Former Chief Executive Officer | $442,337 | $2,192,934 |
| 2022 | enGene Therapeutics Inc. (ENGN) | Chief Executive Officer | $446,419 | $649,207 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.